SAYLOR ANNOUNCED A HUGE BITCOIN SELL (BAD BAD BAD)

Authorized $1.25 billion BTC sale

Strategy's board approved a 'Bitcoin monetization program' allowing sales of up to $1.25 billion to generate US dollar reserves rather than accumulating more BTC.

Funding dividend obligations

Proceeds will pay dividends on preferred stocks like 'Stretch,' cover interest expenses, and potentially repurchase common stock to stabilize crashing share prices.

End of weekly accumulation strategy

The company pivoted from 'one-way capital issuance' to 'active capital management,' ending their consistent weekly Bitcoin purchase strategy used throughout the bull market.

Preferred stocks decouple from parity

Products like 'Stretch' promised to maintain $100 parity with 11.5% yields but have traded 25-28% below par without the promised yield increases to restore the peg.

MNAV collapse forces rule breakage

With the Market Cap to Net Asset Value ratio at 0.62—far below the 1.5 threshold they claimed was necessary for equity raises—Strategy raised capital this week to buy USD instead of Bitcoin.

Saylor's philosophical reversal

Saylor shifted from his famous mantra 'sell a kidney if you must, but keep the Bitcoin' to a new stance of 'buy more Bitcoin than you sell,' acknowledging the necessity of disposals.

Bitcoin breaks 200-week support

BTC crashed to $59,187 following the announcement, confirming a close below the multi-cycle 200-week moving average for the first time since the previous bear market.

Potential for further downside

Historical patterns suggest Bitcoin could decline toward the $42,000-$53,000 range to reach the realized price average, consistent with previous cycle capitulations.

No liquidation risk for Strategy

Despite the bearish pivot, Strategy maintains a 0.13 debt-to-BTC ratio with 10x asset coverage, meaning they cannot be liquidated even if Bitcoin drops 50%.